Xeris Biopharma Holdings Inc (XERS)

Jan 21, 2025

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness - Beloit Daily News

Jan 21, 2025

Jan 21, 2025

ADA Partners With Xeris to Combat Rising Diabetes Emergency Cases Amid 202,000 Annual ER Visits - StockTitan

Jan 21, 2025

Jan 16, 2025

Xeris Biopharma Holdings Inc (XERS) With A Potential Upside Of More Than -103.7% - Stocks Register

Jan 16, 2025

Jan 15, 2025

Barclays PLC Boosts Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jan 15, 2025

Jan 14, 2025

Xeris Biopharma raises FY24 revenue view to $203M from $198M-$202M - MSN

Jan 14, 2025

Jan 11, 2025

Arecor stock plummets after Tetris retreat - Business Weekly

Jan 11, 2025

Jan 10, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Up 5.7%Here's Why - MarketBeat

Jan 10, 2025

Jan 10, 2025

Xeris Expects to Exceed Full-Year 2024 Financial Guidance - BioSpace

Jan 10, 2025

Jan 10, 2025

Xeris Biopharma exceeds 2024 revenue guidance - Investing.com India

Jan 10, 2025

Jan 10, 2025

Xeris Biopharma Exceeds 2024 Guidance with $203M Revenue, Posts Record Q4 Growth - StockTitan

Jan 10, 2025

Jan 07, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Stock Position Lifted by Principal Financial Group Inc. - Defense World

Jan 07, 2025

Jan 07, 2025

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)January 6, 2025 - BioSpace

Jan 07, 2025

Jan 06, 2025

Xeris Biopharma Awards 181,500 RSUs to New Employees in Strategic Talent Acquisition Move - StockTitan

Jan 06, 2025

Jan 02, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Acquired by Geode Capital Management LLC - Defense World

Jan 02, 2025

Jan 01, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Sold by Jane Street Group LLC - Defense World

Jan 01, 2025

Dec 31, 2024

Barclays PLC Purchases 151,685 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat

Dec 31, 2024

Dec 27, 2024

State Street Corp Sells 53,915 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Dec 27, 2024

Dec 20, 2024

Applied Therapeutics Appoints John H. Johnson as Executive Chairman - The Manila Times

Dec 20, 2024

Dec 19, 2024

Xeris Biopharma (NASDAQ:XERS) Shares Up 5.2%What's Next? - MarketBeat

Dec 19, 2024

Dec 08, 2024

Quantbot Technologies LP Purchases Shares of 15,425 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Dec 08, 2024

Dec 03, 2024

Walleye Capital LLC Purchases Shares of 1,121,738 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat

Dec 03, 2024

Dec 02, 2024

Connor Clark & Lunn Investment Management Ltd. Invests $237,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Dec 02, 2024

Nov 27, 2024

XERS (Xeris Biopharma Holdings) Revenue : $187.4 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Nov 26, 2024

Xeris Biopharma Holdings (FRA:2B30) Other Long Term Assets : €4.9 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

XERS (Xeris Biopharma Holdings) Other Stockholders Equity : $0.0 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

XERS (Xeris Biopharma Holdings) EPS (Diluted) : $-0.44 (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

XERS (Xeris Biopharma Holdings) GF Score : 75/100 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

XERS (Xeris Biopharma Holdings) Accounts Payable : $7.5 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

GSA Capital Partners LLP Sells 578,313 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Nov 26, 2024

Nov 26, 2024

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference - Business Wire

Nov 26, 2024

Nov 26, 2024

GSA Capital Partners LLP Trims Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat

Nov 26, 2024

Nov 25, 2024

XERS (Xeris Biopharma Holdings) Cash-to-Debt : 0.26 (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 25, 2024

XERS (Xeris Biopharma Holdings) Shares Outstanding (EOP) : 149.0 Mil (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 25, 2024

XERS (Xeris Biopharma Holdings) Other Current Liabilities : $34.8 Mil (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 17, 2024

Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long - Yahoo Finance

Nov 17, 2024

Nov 16, 2024

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS): When Will It Breakeven? - Simply Wall St

Nov 16, 2024

Nov 14, 2024

HC Wainwright Forecasts Reduced Earnings for Xeris Biopharma - Defense World

Nov 14, 2024

Nov 14, 2024

Wealth Enhancement Advisory Services LLC Invests $35,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Nov 14, 2024

Nov 14, 2024

FY2024 EPS Estimate for Xeris Biopharma Raised by Analyst - Defense World

Nov 14, 2024

Nov 13, 2024

HC Wainwright Forecasts Higher Earnings for Xeris Biopharma - MarketBeat

Nov 13, 2024

Nov 13, 2024

Xeris Biopharma (NASDAQ:XERS) Rating Lowered to Neutral at Piper Sandler - Defense World

Nov 13, 2024

Nov 13, 2024

Xeris Biopharma (NASDAQ:XERS) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World

Nov 13, 2024

Nov 12, 2024

HC Wainwright Forecasts Weaker Earnings for Xeris Biopharma - MarketBeat

Nov 12, 2024

Nov 10, 2024

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 10, 2024

Nov 09, 2024

Earnings call: Xeris Biopharma posts record revenue in Q3 2024 - Investing.com India

Nov 09, 2024

Nov 09, 2024

Earnings call: Xeris Biopharma posts record revenue in Q3 2024 By Investing.com - Investing.com Nigeria

Nov 09, 2024

Nov 09, 2024

Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Nov 09, 2024

Nov 09, 2024

Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highli - GuruFocus.com

Nov 09, 2024

Nov 08, 2024

Xeris Biopharma Reports Record Third Quarter Revenue - TipRanks

Nov 08, 2024